ClinicalTrials.gov
 Home    Search    Study Topics    Glossary  
 

  Full Text View  
  Tabular View  
  Contacts and Locations  
  Related Studies  
Efficacy and Safety of a Purified Standardised Bee Venom Preparation

This study is ongoing, but not recruiting participants.

Sponsored by: Allergopharma Joachim Ganzer KG
Information provided by: Allergopharma Joachim Ganzer KG
ClinicalTrials.gov Identifier: NCT00263952
  Purpose

The trial is performed to assess efficacy and safety of a purified standardised bee venom preparation in bee venom allergy


Condition Intervention Phase
Bee Venom Allergy
 Biological: bee venom
 Phase III

MedlinePlus related topics:   Allergy   

U.S. FDA Resources

Study Type:   Interventional
Study Design:   Treatment, Non-Randomized, Open Label, Historical Control, Single Group Assignment, Safety/Efficacy Study
Official Title:   Immunotherapy of Bee Venom Allergy: Evaluation of a New Purified Bee Venom Preparation in Comparison With Already Published Studies.

Further study details as provided by Allergopharma Joachim Ganzer KG:

Study Start Date:   March 2003
Estimated Study Completion Date:   April 2010

  Eligibility
Ages Eligible for Study:   18 Years to 65 Years
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No

Criteria

Inclusion Criteria:

  • History of bee venom allergy,
  • Positive RAST for bee venom,
  • Positive skin prick test for bee venom

Exclusion Criteria:

  • Serious chronic diseases
  Contacts and Locations

Please refer to this study by its ClinicalTrials.gov identifier: NCT00263952

Locations
Germany
Allergopharma Joachim Ganzer KG    
      Reinbek, Germany, 21465

Sponsors and Collaborators
Allergopharma Joachim Ganzer KG

Investigators
Principal Investigator:     Annemie Narkus, M.D.     unaffiliated    
  More Information

Leader in specific allergy research and therapy  This link exits the ClinicalTrials.gov site
 

Study ID Numbers:   Al0202ig
First Received:   December 9, 2005
Last Updated:   July 16, 2008
ClinicalTrials.gov Identifier:   NCT00263952
Health Authority:   Germany: Paul-Ehrlich-Institut

Keywords provided by Allergopharma Joachim Ganzer KG:
Bee venom allergy  
Specific immunotherapy  

Study placed in the following topic categories:
Hypersensitivity
Hypersensitivity, Immediate

Additional relevant MeSH terms:
Immune System Diseases

ClinicalTrials.gov processed this record on September 05, 2008

U.S. National Library of Medicine,  Contact Help Desk
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act
U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services



Links to all studies - primarily for crawlers